Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 6, 1998, Pages 913-921

  Ye, Hongqing Q ^a   Azar, Dimitri T ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; CORNEA STROMA; EXCIMER LASER; KERATECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION; WOUND HEALING;

ANIMALS; COLLAGENASES; CORNEA; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GELATINASES; IN SITU HYBRIDIZATION; LASER SURGERY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICROSCOPY, CONFOCAL; RATS; RATS, SPRAGUE-DAWLEY; RNA PROBES; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; WOUND HEALING;

EID: 0031980284     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stetler-Stevenson SW, Liotta LA, Kleiner DJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993;7:1434-1441.
2. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activation of MMPs and their regulators in ovarian cancer. Int J Cancer. 1994;58:50-56.
3. McDonnell S, Navre M, Coffey RJ, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1(MMP-7) in human gastric and colon carcinomas. Mol Carcinog. 1991;4:527-533.
4. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 1994;37:1115-1126.
5. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl. 1992; 202:26-33.
6. Woessner JJ. The family of matrix metalloproteinases. Ann N Y Acad Sci. 1994;732:11-21.
7. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol. 1991;147:425-439.
8. Azar DT, Hahn TW, Jain S, Yeh YC, Stetler-Stevenson SW. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996;15:18-24.
9. Kleiner DJ, Stetler-Stevenson SW. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol. 1993; 5:891-897.
10. Poulsom R, Hanby AM, Pignatelli M, et al. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol. 1993;46:429-436.
11. Bord S, Horner A, Hembry RM, Reynolds JJ, Compston JE. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. J Anat. 1997;191:39-48.
12. Robert V, Besse S, Sabri A, et al. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br J Cancer. 1997;75:1678-1683.
13. Freestone T, Turner RJ, Higman DJ, Lever MJ, Powell JT. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett. 1997;401:213-217.
14. Itoh Y, Binner S, Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J. 1995;308:645-651.
15. Stetler SW. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 1990;9:289-303.
16. Xia M, Sreedharan SP, Dazin P, Damsky CH, Goetzl EJ. Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J Cell Biochem. 1996;61:452-458.
17. Fini ME, Girard MT. The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci. 1990;97:373-383.
18. Matrisian LM. Matrix metalloproteinase gene expression. Ann N Y Acad Sci. 1994;732:42-50.
19. Ye H, Yang J, Hernandez MR. Localization of collagen type III mRNA in normal human optic nerve heads. Exp Eye Res. 1994;58: 53-63.
20. Fini ME, Cui TY, Mouldovan A, Grobelny D, Galardy RE, Fisher SJ. An inhibitor of the matrix metalloproteinase synthesized by rabbit corneal epithelium. Invest Ophthalmol Vis Sci. 1991;32:2997-3001.
21. Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 1991;32:3221-3237.
22. Fini ME, Parks WC, Rinehart WB, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996;149:1287-1302.
23. Power WJ, Kaufman AH, Merayo LJ, Ammategui CV, Foster CS. Expression of collagens I, III, IV and V mRNA in excimer wounded rat cornea: analysis by semi-quantitative PCR. Curr Eye Res. 1995; 14:879-886.
24. Azar DT, Chamon W, Green WR, Stark WJ. Time and pattern of epithelial and stromal healing following superficial concentric photorefractive keratectomies. Invest Ophthalmol Vis Sci. 1992; 33(suppl);766.
25. Jain S, Chamon W, Stark WJ, Green WR, Prendergast RA, Azar DT. Intrastromal epithelial accretion follows deep excimer annular keratectomy. Cornea. 1996;15:248-257.
26. Fountain TR, de la Cruz Z, Green WR, Stark WJ, Azar DT. Reassembly of corneal epithelial adhesion structures after excimer laser keratectomy in humans. Arch Ophthalmol. 1994;112: 967-972.